Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) shares, rose in value on Thursday, March 27, without any change to the previous day’s close as strong demand from buyers drove the stock to $1.46.
Actively observing the price movement in the last trading, the stock closed the session at $1.46, falling within a range of $1.41 and $1.49. The value of beta (5-year monthly) was 0.366 whereas the PE ratio was 135.19 over 12-month period. Referring to stock’s 52-week performance, its high was $9.01, and the low was $1.34. On the whole, IRWD has fluctuated by -14.62% over the past month.
With the market capitalization of Ironwood Pharmaceuticals Inc currently standing at about $233.64 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 287.07M, with a low estimate of 56M and a high estimate of 79.9M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 67.02M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IRWD’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of IRWD currently trading nearly -2.63% and -31.25% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 35.90, while the 7-day volatility ratio is showing 8.54% which for the 30-day chart, stands at 9.13%. Furthermore, Ironwood Pharmaceuticals Inc (IRWD)’s beta value is 0.30, and its average true range (ATR) is 0.14.
A comparison of Ironwood Pharmaceuticals Inc (IRWD) with its peers suggests the former has fared considerably weaker in the market. IRWD showed an intraday change of 0.00% in last session, and over the past year, it shrunk by -82.64%%.
Data on historical trading for Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) indicates that the trading volumes over the past 10 days have averaged 3.38 and over the past 3 months, they’ve averaged 3.29 million. According to company’s latest data on outstanding shares, there are 160.03 million shares outstanding.
Nearly 3.02% of Ironwood Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 102.98% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 16.25 million shares as on 2025-03-14, resulting in a short ratio of 6.49. According to the data, the short interest in Ironwood Pharmaceuticals Inc (IRWD) stood at 1962.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 10.7 million. The stock has fallen by -67.04% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IRWD stock heading into the next quarter.
